Tipranks Press Release.
Investors seeking a high yield and stable fundamentals in the healthcare sector need look no further than Bristol Myers Squibb.
Wall Street analysts react to the outcome of SpaceX's Starship flight 14 mission on Monday, eye potential for future launches.
Ligand Pharmaceuticals recently entered a US$47 million financing agreement with AvenCell Therapeutics, including up to US$6 million in Series C funding and as much as US$41 million tied to clinical milestones for AvenCell’s CAR-T therapy programs. The deal deepens Ligand’s royalty-focused model by adding potential royalty streams on AvenCell’s current and future pipeline, further broadening its portfolio of over 200 partnered assets following the XOMA Royalty acquisition. We’ll now examine...
Detailed price information for Ligand Pharm (LGND-Q) from The Globe and Mail including charting and trades.
Detailed price information for Ligand Pharm (LGND-Q) from The Globe and Mail including charting and trades.
This is the newest page. Registered accounts read further back.